!-- Nivo Slider Theme -->
×
Join Us to be Part of a Robust Community Aimed at Translating Consumer Perceptions into Business Opportunities Benefit from a Complimentary Dialog with our Growth Coaches and Assess Your Company's Growth Strategy MedTech Sustainability: New Business Models Emphasizing Novel Growth Prospects What are the Latest Growth Avenues for Life Science Instruments and Tools? US Healthcare Claims Management: Major Growth Prospects Revealed What is the Innovative Growth Potential for Cloud-based Medical Imaging Informatics?

Top Growth Opportunities

Which Transformational Growth Opportunities are Redefining the Global Cardiac Rhythm Management Devices Sector?
Which Transformational Growth Opportunities are Redefining the Global Cardiac Rhythm Management Devices Sector?

Understand the innovative business models and advanced predictive solutions that can be cost-effective, easy to deploy, and have a better reach. Analyze the transformational capabilities, new pathways, and technologies for connectivity and continuous monitoring.

Read more Request Info
What are the Innovative Growth Prospects for Healthcare IT Tools Supporting the US Digital Pharmacy Sector?
Growth Opportunities for Healthcare Information Technology Tools Supporting the United States Digital Pharmacy Sector

How has the COVID-19 pandemic accelerated the application of digital health and virtual care across all healthcare verticals? Examine the technological innovations across the care continuum like ePrescriptions, telepharmacy, patient engagement, and instant medication home delivery.

Read more Request Info
How are Emerging Growth Strategies Redefining the Vendor Neutral Archiving Solutions Sector?
How are Emerging Growth Opportunities Redefining the Vendor Neutral Archiving Solutions Sector?

Assess the software, platform, and professional services that are extensively utilized to establish a repository of images and data. Explore how vendor neutral archiving solutions enable healthcare professionals with single-point access to standardized and consolidated imaging data.

Read more Request Info

CxO Analytics

Healthcare Delivery Sector

Strategic Imperatives in the Crowded 2023 Healthcare Delivery Sector

Greg Caressi
Senior Vice President and Global Client Leader

Changes in Care Delivery Models

Over the past five years, there has been an expansion in care delivery models in healthcare. Traditional healthcare providers are a leading force in this change, expanding their footprint geographically and in the range of services offered. Health systems have merged or acquired standalone facilities, bought primary care practices, opened urgent care centers to expand their reach and provide a lower-cost alternative to emergency rooms for after-hours issues, and partnered with ambulatory surgery centers as more procedures move out of hospitals. During the pandemic, almost every healthcare provider offered virtual visits to continue seeing patients, and many added remote monitoring services and hospital at-home programs to better track patients with chronic conditions or better manage post-acute care recovery.

Schedule a dialog or email us at myfrost@frost.com to connect with an industry expert at no charge. We are taking unprecedented action to make our team available to help you cut through the media and politics to get factual one-to-one guidance for the issues and opportunities that matter most to your business.

Frost Radars & Sector-Based Opportunities

Frost Radar—Global Medical Imaging Managed Equipment Services
Medical Imaging Equipment

How does this sector offer technical infrastructure support and drive growth?

Read more Request Info
Frost Radar—Cell and Gene Therapy Contract Development and Manufacturing Organizations
Cell and Gene Therapy

Explore how contract development and manufacturing organizations are growing

Read more Request Info
What is the Growth Potential of the Life Sciences Sector in 2023?
Life Sciences

How are factors like geopolitical chaos creating innovative growth opportunities?

Read more Request Info
What are the Growth Opportunities and Innovative Use Cases for AI in Clinical Trials?
Artificial Intelligence-Clinical Trials

What is the role of randomized control trials in the growth of this landscape?

Read more Request Info
PCR-based PoC Platforms for Infectious Disease Testing: What are the New Growth Hubs?
PCR-based PoC Platforms

Examine the impact of performance, turnaround times, and more on this sector’s growth

Read more Request Info
What Growth Strategies are Transforming the Pharmaceutical Continuous Manufacturing Sector?
Pharma Continuous Manufacturing

Which drugs have been approved for manufacture with this sector’s processes?

Read more Request Info
Which Developments are Driving Growth in the Respiratory Monitoring Solutions Space?
Respiratory Monitoring

Assess the growth of major segments like oxygen concentrators, pulse oximeters, and more

Read more Request Info
Physician Offices/Labs in Decentralized Testing and Services: New Growth Indicators Revealed
Decentralized Testing

How are clinical laboratories and diagnostic companies influencing this sector’s growth?

Read more Request Info

Blogs

With an FDI of over $19 billion up to 2022, an outlay of $26.5 billion as a part of the PLI scheme (covering 13 sectors), and an expected $419.2 million investment in R&D in 2023, the Indian pharmaceutical sector is set to witness growth in 2023. Additionally, with investments in R&D, the budget is a precursor to the strategic imperatives driving the Prime Minister’s vision of Universal Healthcare, the “Atmanirbhar Bharat” vision for innovation in advanced therapies, and the G20 Presidency agenda of healing, harmony, and hope. Moreover, the announcements provide continuity to the “Pharma Vision 2020,” initiated by the Department of Pharmaceuticals, which aims to position the country as a global hub for end-to-end drug discovery.
Read more

Frost & Sullivan recently analyzed the Asia-Pacific contract research organization sector and, based on its findings, recognizes Novotech with the 2022 Asia-Pacific Contract Research Organization Company of the Year Award. The company has a regional presence across eleven Asia-Pacific (APAC) countries, including China, India, Thailand, Malaysia, Australia, and South Korea. Novotech has more than 2,500 team members providing end-to-end clinical development support to more than 600 biotechnology clients covering all clinical trial phases in APAC, Europe, and North America.
Read more

2022 was the year that saw rising demand for healthcare services, an increasing focus on preventative care and wellness, and greater collaboration between the public and private sectors in the Middle East region. With the increasing demand for personalized and specialty care and changes in healthcare regulation and policy, the region saw growing investments in digital health technologies (Cloud, 5G, IoT, and so on), value-based care, and an increasing focus on sustainability and environmental health.
Read more

Press Releases

Flagship Biosciences Applauded by Frost & Sullivan for Changing Biomarker Analysis to Find Biomarkers that Aid Drug Development and Diagnostics

Frost & Sullivan assessed the artificial intelligence (AI)-enabled digital pathology solutions sector, and based on its findings, recognizes Flagship Biosciences with the 2023 North American Customer Value Leadership Award. The company is a technology-driven spatial biology and biomarker analytics service provider using the most precise and comprehensive data. The company’s consultative approach and cutting-edge AI are changing biomarker analysis to enhance drug development and diagnostics. It uniquely leverages its technology to meet its customers’ needs.

Read more

Women’s Evolving Healthcare Issues Require Change in Mindset as well as Holistic and Personalized Care Delivery Models

Frost & Sullivan’s recent analysis, Reimagining Women’s Health, presented at Arab Health by our Healthcare and Life Sciences Partner and Senior Vice President, Reenita Das, focuses on the evolving healthcare issues of women, such as menopause and infertility. She urges the healthcare sector to address them by developing holistic and personalized care delivery models.

Read more

NetApp Applauded by Frost & Sullivan for Addressing Complex and Constantly Evolving Healthcare and Life Sciences Challenges with its Cloud Services

Frost & Sullivan recently analyzed the healthcare cloud sector and, based on its findings, recognizes NetApp with the 2022 Global Technology Innovation Leadership Award. The company is a leading global platform-as-a-service healthcare cloud services provider that leverages its extensive experience and complete cloud solutions portfolio to accelerate innovation while unlocking the potential of the cloud and improving data protection. It increasingly adopts strategies to manage data efficiently, eliminates information silos, optimizes resources, reduces data center footprints, and leverages artificial intelligence (AI) to drive actionable ideas. NetApp delivers industry-leading data management and storage solutions on AWS, Azure, and Google Cloud. The company helps customers better manage, protect, move, and store their data while remaining agnostic about the data location: on-premises, private cloud, public cloud, hybrid cloud, or multi-cloud environments.

Read more

What's New?

Frost & Sullivan Think Tanks
  • Follow us  

Subscribe to the Healthcare & Life Sciences Newsletter

Subscribe

Featured

Upcoming Events

Customer Contact East
Innovation Workshop and Tour
Customer Experience Ecosystem
Customer Experience Ecosystem

Frost & Sullivan Institute

FSIbanner

Click here to know more

Advertisement Queries

AD_banner

Click Here For More Info